Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century

Although most 21st-century media coverage of psychedelic drugs has been positively framed, negative and neutral coverage has increased in frequency since 2020. Researchers, clinicians, regulators and policy-makers should be mindful of the complex relationship between media portrayals of psychedelics and the results of scientific research.

Authors

Institutions

Publication Details

Journal
BJPsych Open
Published
2026-02-12
DOI
https://doi.org/10.1192/bjo.2025.10974
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century

Madeline Villalba, M.K. Iyer, Reetwan Bandyopadhyay, Barış Erçal et al.
BJPsych Open
Psychedelics and Drug Studies
article

Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century

Madeline Villalba, M.K. Iyer, Reetwan Bandyopadhyay, Barış Erçal, Zaryab Alam, Akila Anandarajah, Brendan Ross, David J. Hellerstein, Charles B. Nemeroff, Brandon J. Kiley, Syed Ali Ahmed, David A. Bender, Holly Dunn, Hannah Wang, Jacob T. Steinle, Suraj Shankar, Kayla Smart, Arushi D. Mohite, Rana Abdalla, Juy Yusuf, Melinda Daniels-Tineo, Umer Jalil, Madison K. Stille, Mia Stonov, Anvi Divekar, Amanda Pekau, Gibson Werner, Sonali Sharma, Nithya Pippala, Rishi Gonuguntla, Sophia Chertock, Sara Martin, Jatin Sridhar, Adebusola Adeyemi
article en

Abstract

Although most 21st-century media coverage of psychedelic drugs has been positively framed, negative and neutral coverage has increased in frequency since 2020. Researchers, clinicians, regulators and policy-makers should be mindful of the complex relationship between media portrayals of psychedelics and the results of scientific research.

BJPsych OpenVol. 12(2)
Texas A&M Health Science Center (US), BJC HealthCare (US), Harvard University (US), University of Illinois Urbana-Champaign (US), Washington University in St. Louis (US), The University of Texas Rio Grande Valley (US), Columbia College (CA), Royal College of Physicians (GB), New York State Psychiatric Institute, University of the Incarnate Word (US), Columbia University (US), The University of Texas Health Science Center at Houston (US), Icahn School of Medicine at Mount Sinai (US)
Johns Hopkins University, ACADIA Pharmaceuticals, Neurocrine Biosciences, Sage Therapeutics, National Institutes of Health, National Institute of Mental Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Openalex Percentile: Top 60%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.